Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Welch Allyn is a legacy healthcare and medical device company best known for diagnostic and patient-monitoring equipment used in hospitals, clinics, and physician offices. Its portfolio includes vital-signs monitors, blood pressure devices, electrocardiography systems, thermometers, ophthalmoscopes, otoscopes, vision-screening products, and related digital diagnostic tools. The company was acquired by Hillrom in 2015, and Hillrom was subsequently acquired by Baxter in 2021; Welch Allyn continues primarily as a product brand within Baxter's connected care and diagnostics portfolio. It is not a therapeutics developer and does not have a drug pipeline in the biotech/pharma sense. The business is focused on commercialized medical technologies rather than clinical-stage drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Welch.